Device Trial Radar · NCT07103057
VIZ ACCESS HCM - Multi-Site Registry
Last checked: Nov 20, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
17
Actual
Start
Jun 13, 2025
Primary completion
Sep 17, 2026
Study completion Sep 17, 2026
Sponsor
- Lead sponsor
- Viz.ai, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 5, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Conditions
- Hypertrophic Cardiomyopathy
Interventions
Viz HCMDevice
Viz HCM is a Software as a Medical Device (SaMD) intended to receive 12-lead ECG recordings collected as part of a routine clinical assessment and analyze them in parallel to the standard of care. The device uses a machine learning based algorithm to analyze 12-lead ECGs and identify ECGs with suspected HCM.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical characteristics of Viz HCM AI screening on HCM diagnosisTime frame: Up to 3 years
- Clinical characteristics of Viz HCM AI screening on medical workup.Time frame: Up to 3 years
- Clinical characteristics of Viz HCM AI screening on treatment plans.Time frame: Up to 3 years
7 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Emory University
Atlanta, Georgia
North Shore University Health System
Evanston, Illinois
Thomas Jefferson University
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.